The impact of rotavirus gastroenteritis on the family
Tóm tắt
Rotavirus is the leading cause of severe diarrhea in young children and causes substantial morbidity and mortality. Although the clinical aspects have been well described, little information is available regarding the emotional, social, and economic impact of rotavirus gastroenteritis on the family of a sick child. The objectives of this study were to: 1) assess the family impact of rotavirus gastroenteritis through qualitative interviews with parents; 2) compare the clinical severity of rotavirus-positive and negative gastroenteritis; 3) test a questionnaire asking parents to rank the importance of various factors associated with a case of rotavirus gastroenteritis. The study enrolled parents and children (2–36 months of age) brought to one of the study sites (outpatient clinic or ER) if the child experienced ≥ 3 watery or looser-than normal stools and/or forceful vomiting within any 24-hour period within the prior 3 days. The clinical severity of each child's illness was rated using a clinical scoring system and stool samples were tested for rotavirus antigen. Parents of rotavirus-positive children were invited to participate in focus group or individual interviews and subsequently completed a questionnaire regarding the impact of their child's illness. Of 62 enrolled children, 43 stool samples were collected and 63% tested positive for rotavirus. Illness was more severe in children with rotavirus-positive compared to rotavirus-negative gastroenteritis (92% vs. 37.5% rated as moderate/severe). Seventeen parents of rotavirus-positive children participated in the interviews and completed the written questionnaire. Parents were frightened by the severity of vomiting and diarrhea associated with rotavirus gastroenteritis, and noted that family life was impacted in several ways including loss of sleep, missed work, and an inability to complete normal household tasks. They expressed frustration at the lack of a specific medication and the difficulty of treating the illness with oral rehydration solutions, but had a largely positive outlook concerning the prospect of a rotavirus vaccine. A better understanding of how rotavirus gastroenteritis impacts the family can help healthcare providers ease parental fears and advise them on the characteristics of this illness, practices to prevent infection, and the optimal care of an affected child.
Tài liệu tham khảo
Bishop RF, Davidson GP, Holmes IH, Ruck BJ: Virus particles in epithelial cells of duodenal mucosa from children with acute gastroenteritis. Lancet. 1973, 2: 1281-1283. 10.1016/S0140-6736(73)92867-5.
Kapikian AZ, Chanock RM: Rotaviruses. Virology. Edited by: Fields BN, Knipe DM, Howley PM. 1996, Philadelphia: Lippincott-Raven Publishers, 1657-1708.
Centers for Disease Control and Prevention, et al: Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006, 55 (RR-12): 1-13.
Parashar UD, Gibson CJ, Bresee JS, Glass RI: Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006, 12: 304-306.
Baum F: Researching public health: behind the qualitative-quantitative methodological debate. Soc Sci Med. 1995, 40: 459-468. 10.1016/0277-9536(94)E0103-Y.
Centers for Disease Control and Prevention: Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003, 52 (RR-16): 1-16.
McKenna SP, Hunt SM: A measure of family disruption for use in chickenpox and other childhood illnesses. Soc Sci Med. 1994, 38: 725-731. 10.1016/0277-9536(94)90463-4.
Imms C: Impact on parents of feeding young children with congenital or acquired cardiac disease. Cardiol Young. 2000, 10: 574-581. 10.1017/S1047951100008842.
Balkrishnan R, Housman TS, Carroll C, Feldman SR, Fleischer AB: Disease severity and associated family impact in childhood atopic dermatitis. Arch Dis Child. 2003, 88: 423-427. 10.1136/adc.88.5.423.
Stein RE, Jessop DJ: The impact of family scale revisited: further psychometric data. J Dev Behav Pediatr. 2003, 24: 9-16. 10.1097/00004703-200312000-00008.
Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA: Protective efficacy of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis. 1988, 158: 570-587.
Centers for Disease Control and Prevention: Laboratory-based surveillance for rotavirus–United States, July 1996-June 1997. MMWR Morb Mortal Wkly Rep. 1997, 46: 1092-1094.
Staat MA, Azimi PH, Berke T, Roberts N, Bernstein DI, Ward RL, Pickering LK, Matson DO: Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002, 21: 221-227. 10.1097/00006454-200203000-00012.
Coffin SE, Elser J, Marchant C, Sawyer M, Pollara B, Fayorsey R, Nelson L, Lawley D, Goveia M, Stek J, Hille D, DiNubilie MJ: Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J. 2006, 25: 584-589. 10.1097/01.inf.0000220251.27595.74.
Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S, Izzi G, Virdis R, Pecco P, Principi N, Fontana M, Guarino A: Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr. 2007, 166: 241-247. 10.1007/s00431-006-0237-6.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006, 354: 23-33. 10.1056/NEJMoa052664.
Centers for Disease Control and Prevention: Delayed Onset and Diminished Magnitude of Rotavirus Activity — United States, November 2007–May 2008. MMWR Morb Mortal Wkly Rep. 2008, 57: 697-700.
Patel MM, Janssen AP, Tardif RR, Herring M, Parashar UD: A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers. BMC Pediatr. 2007, 7: 32-10.1186/1471-2431-7-32.
Simpson E, Wittet S, Bonilla J, Gamazina K, Cooley L, Winkler JL: Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries. BMC Public Health. 2007, 7: 281-10.1186/1471-2458-7-281.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/9/11/prepub